Scarsini R., Shanmuganathan M., Kotronias RA., Terentes-Printzios D., Borlotti A., Langrish JP., Lucking AJ., OxAMI Study Investigators None., Ribichini F., Ferreira VM., Channon KM., Garcia-Garcia HM., Banning AP., De Maria GL.

To investigate the diagnostic accuracy of (1) hyperaemic angiography-derived index of microcirculatory resistance (IMRangio) in defining coronary microvascular dysfunction (CMD) across patients with acute coronary syndromes (ST-elevation myocardial infarction [STEMI]; non-ST elevation acute coronary syndrome [NSTE-ACS]) and stable chronic coronary syndrome [CCS]) and (2) the accuracy of non-hyperaemic IMRangio (NH-IMRangio) to detect CMD in STEMI. 145 patients (STEMI = 66; NSTEMI = 43; CCS = 36) were enrolled. 246 pressure-wire IMR measurements were made in 189 coronary vessels. IMRangio and NH-IMRangio was derived using quantitative flow ratio. In patients with STEMI, cardiac magnetic resonance was performed to quantify microvascular obstruction (MVO). IMRangio was correlated with IMR (overall rho = 0.78, p

Angiography-derived index of microcirculatory resistance (IMRangio) as a novel pressure-wire-free tool to assess coronary microvascular dysfunction in acute coronary syndromes and stable coronary artery disease.

Scarsini R., Shanmuganathan M., Kotronias RA., Terentes-Printzios D., Borlotti A., Langrish JP., Lucking AJ., OxAMI Study Investigators None., Ribichini F., Ferreira VM., Channon KM., Garcia-Garcia HM., Banning AP., De Maria GL.

DOI

Type

Journal

Publication Date

Keywords